CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January 19, 2020. Barrett previously served as CardioFocus’ president and chief operating officer (COO).
The company is developing devices for ablation treatment for atrial fibrillation (AF), which includes the HeartLight System, a catheter ablation technology for controlled and consistent pulmonary vein isolation (PVI).
“The board of directors are proud to announce Burke’s promotion to CEO,” said Paul LaViolette, executive chairman of CardioFocus of the appointment. “From the outset, Burke has played an integral role in the development of the HeartLight platform as well as CardioFocus as a company. He is intimately familiar with our technology, employees, investors, customers, regulators, vendors and distributors, and is the perfect person to lead the company as we introduce the breakthrough HeartLight X3 System to the global AF market.”
“I am as excited as ever about the future of CardioFocus given the impressive clinical and commercial results coming out of Europe with our HeartLight X3 System,” said Mr. Barrett. “We are pleased to showcase the System at the 25th Annual International AF Symposium being held in Washington DC this week and plan to provide an update about the regulatory path and timeline for introduction of the System into the US market in the coming weeks.”
Barrett has over 30 years of experience in the medical device industry and joined CardioFocus in 2002.